Because of the importance of the maltenepolymer interaction for the better performance of polymermodified asphalts, this article reports the effects of the molecular characteristics of two commercial poly(styreneblock-butadiene-block-styrene-block) (SBS) polymers and their partially hydrogenated derivatives [poly{styrene-block[(butadiene) 1Àx -(ethylene-co-butylene) x ]-block-styreneblock} (SBEBS)] on the morphology and rheological behavior of maltene-polymer blends (MPBs) with polymer concentrations of 3 and 10% (w/w). Each SBEBS and its parent SBS had the same molecular weight and polystyrene block size, but they differed from each other in the composition of the elastomeric block, which exhibited the semicrystalline characteristics of SBEBS. Maltenes were obtained from Ac-20 asphalt (Pemex, Salamanca, Mexico), and the blends were prepared by a hot-mixing procedure. Fluorescence microscopy images indicated that all the blends were heterogeneous, with polymer-rich and maltene-rich phases. The rheological behavior of the blends was determined from oscillatory shear flow data. An analysis of the storage modulus, loss modulus, complex modulus, and phase angle as a function of the oscillatory frequency at various temperatures allowed us to conclude that the maltenes behaved as pseudohomogeneous viscoelastic materials that could dissipate stress without presenting structural changes; moreover, all the MPBs were more viscoelastic than the neat maltenes, and this depended on both the characteristics and amount of the polymer. The MPBs prepared with SBEBS were more viscoelastic and possessed higher elasticity than those prepared with SBS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.